IL17A and psoriasis: Our current study showed that the expression of IL23A in both mature and semimature DCs was decreased after systemic IL-17A blockade in posttreatment psoriasis lesional skin compared to pretreatment psoriasis lesional skin (Figure 5A, p < 0.05).